Status:
COMPLETED
Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
PHASE2
Brief Summary
The concept behind our study was to combine an effect of antibiotic and anti-inflammatory agents for a more efficient acne therapy directed at the factors involved in the pathophysiology of the diseas...
Eligibility Criteria
Inclusion
- mild to moderate acne vulgaris;
- at least 5 lesions on the face;
- a one-month wash-out period was established for any topical or systemic drug use for treatment of acne vulgaris.
Exclusion
- acne that was primarily truncal, nodular, or due to secondary causes/internal disease;
- pregnancy, breastfeeding, or intention to become pregnant;
- another dermatological disease of the face;
- significant systemic disease;
- any drug/alcohol addiction;
- interacting medication;
- known hypersensitivity to study medications;
- history of chronic disease treated with medications which might affect acne condition and treatment outcome (e.g. corticosteroids, lithium, isoniazid, anti-androgens, phenytoin, phenobarbital) in the preceding month
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00361322
Start Date
April 1 2005
End Date
January 1 2006
Last Update
August 8 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120